Treatment and Management of Lung Large Cell Neuroendocrine Carcinoma (LCNEC) - Episode 6

Lung LCNEC Diagnostic Challenges

,

Panelists discuss the challenges encountered with molecular or pathology testing for lung large cell neuroendocrine carcinoma (LCNEC) and how treatment plans are determined when testing is not feasible.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected
    EP. 1: Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro
    EP. 2: An Overview of the Molecular Characterization of Lung LCNEC
    EP. 3: The Pathological Diagnosis of Lung LCNEC
    EP. 4: Biomarker Testing Strategies for Lung LCNEC
    EP. 5: Biopsy Best Practices: Diagnosing Lung LCNEC
    Now Viewing
    EP. 6: Lung LCNEC Diagnostic Challenges
    EP. 7: A Multidisciplinary Approach to Managing Lung LCNEC
    EP. 8: Lung LCNEC Disease Histology and Prognosis
    EP. 9: The Role of DLL3 in LCNEC of the Lung
    EP. 10: Insights on the LANCE Pilot Study on Lung LCNEC
    EP. 11: Novel Targeted Therapies for LCNEC of the Lung
    EP. 12: Overview of Studies of BI 764532 for Lung LCNEC
    EP. 13: Insights Into Ongoing Investigational Studies in Lung LCNEC
    EP. 14: Potential Next-Generation Therapies for Lung LCNEC
    EP. 15: Unmet Needs in LCNEC
    • Do you encounter challenges with performing molecular or pathology testing?
    • If you are unable to perform testing, how do you determine your treatment plan?
    x